PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-68.47%
Negative revenue growth while PONY stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-65.37%
Negative gross profit growth while PONY is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
6.14%
Operating income growth of 6.14% while PONY is zero. Bruce Berkowitz would see if this modest edge can become significant.
10.76%
Net income growth of 10.76% while PONY is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
7.69%
EPS growth of 7.69% while PONY is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
7.69%
Diluted EPS growth of 7.69% while PONY is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-0.00%
Share reduction while PONY is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.88%
OCF growth of 49.88% while PONY is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
49.71%
FCF growth of 49.71% while PONY is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-97.45%
Negative 10Y revenue/share CAGR while PONY stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-96.44%
Negative 5Y CAGR while PONY stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-90.02%
Negative 3Y CAGR while PONY stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
115.36%
OCF/share CAGR of 115.36% while PONY is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-73.17%
Negative 5Y OCF/share CAGR while PONY is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
185.35%
3Y OCF/share CAGR of 185.35% while PONY is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-313.99%
Negative 10Y net income/share CAGR while PONY is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-501.36%
Negative 5Y net income/share CAGR while PONY is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1283.84%
Negative 3Y CAGR while PONY is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-28.65%
Negative equity/share CAGR over 10 years while PONY stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-32.91%
Negative 5Y equity/share growth while PONY is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-33.75%
Negative 3Y equity/share growth while PONY is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while PONY stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-70.56%
Firm’s AR is declining while PONY shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-53.13%
Inventory is declining while PONY stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.37%
Negative asset growth while PONY invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.24%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-20.58%
We’re deleveraging while PONY stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-67.07%
Our R&D shrinks while PONY invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.36%
We cut SG&A while PONY invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.